CAMSAP1 Mutation Correlates With Improved Prognosis in Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy

CAMSAP1 Mutation Correlates With Improved Prognosis in Small Cell Lung Cancer Patients Treated With Platinum-Based Chemotherapy

Platinum-based chemotherapy is the first-line treatment for small cell lung cancer (SCLC). However, due to patients developing a resistance to the drug, most experience relapse and their cancer can become untreatable. A large number of recent studies have found that platinum drug sensitivity of vari...

Full description

Bibliographic Details
Main Authors: Yonglin Yi, Zhengang Qiu, Zifu Yao, Anqi Lin, Yimin Qin, Ruizhan Sha, Ting Wei, Yanru Wang, Quan Cheng, Jian Zhang, Peng Luo, Weitao Shen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Cell and Developmental Biology
Subjects:
small cell lung cancer
CAMSAP1
platinum-based chemotherapy
drug sensitivity
biomarker
Online Access:https://www.frontiersin.org/articles/10.3389/fcell.2021.770811/full

Similar Items

Similar Items